These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 6194254
1. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment. Beckmann H, Waldmeier P, Lauber J, Gattaz WF. J Neural Transm; 1983; 57(1-2):103-10. PubMed ID: 6194254 [Abstract] [Full Text] [Related]
9. Biogenic amine metabolites in human CSF after hypoxia due to cardiac arrest. Odink J, Kärkelä J, Thissen JT, Marnela KM. Acta Neurol Scand; 1989 Jul; 80(1):6-11. PubMed ID: 2476907 [Abstract] [Full Text] [Related]
10. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment. Kahn RS, Davidson M, Knott P, Stern RG, Apter S, Davis KL. Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208 [Abstract] [Full Text] [Related]
12. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Scheinin M. Med Biol; 1985 Jan; 63(1):1-17. PubMed ID: 2582215 [Abstract] [Full Text] [Related]
13. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning. Varela M, Alexiou GA, Liakopoulou M, Papakonstantinou E, Pitsouni D, Alevizopoulos GA. J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277 [Abstract] [Full Text] [Related]
14. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system. González-Quevedo A, García JC, Fernández R, Fernández Cartaya L. Bol Estud Med Biol; 1993 Apr; 41(1-4):13-9. PubMed ID: 7521168 [Abstract] [Full Text] [Related]
15. Monoamine metabolites in cerebrospinal fluid during and after acute cerebral ischemia. Tang HZ, Lu XF, Wang KJ, Ouyang S, Huang YQ. Mol Chem Neuropathol; 1989 Apr; 10(2):77-85. PubMed ID: 2472800 [Abstract] [Full Text] [Related]
17. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage. von Holst H, Lindquist C, Sedvall G. Acta Neurochir (Wien); 1985 Apr; 77(3-4):146-51. PubMed ID: 2416192 [Abstract] [Full Text] [Related]
18. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Engström G, Alling C, Blennow K, Regnéll G, Träskman-Bendz L. Eur Neuropsychopharmacol; 1999 Sep; 9(5):399-405. PubMed ID: 10523046 [Abstract] [Full Text] [Related]
19. Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia. Bråne G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A. Alzheimer Dis Assoc Disord; 1989 Sep; 3(3):148-56. PubMed ID: 2477044 [Abstract] [Full Text] [Related]
20. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence. Ogawa S, Tsuchimine S, Kunugi H. J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563 [Abstract] [Full Text] [Related] Page: [Next] [New Search]